BioScrip Inc  

(Public, NASDAQ:BIOS)   Watch this stock  
Find more results for BIOS
+0.01 (0.19%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.15 - 5.34
52 week 3.41 - 8.75
Open 5.27
Vol / Avg. 434,660.00/1.51M
Mkt cap 361.03M
P/E     -
Div/yield     -
EPS -2.09
Shares 68.64M
Beta 0.85
Inst. own 103%
May 6, 2015
Q1 2015 BioScrip Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 2, 2015
Q4 2014 BioScrip Inc Earnings Release
Mar 2, 2015
Q4 2014 BioScrip Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -24.42% -14.57%
Operating margin -19.59% -9.50%
EBITD margin - -3.51%
Return on average assets -29.51% -16.28%
Return on average equity -100.31% -50.19%
Employees 1,955 -
CDP Score - -


100 Clearbrook Rd
ELMSFORD, NY 10523-1116
United States - Map
+1-914-4601600 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


BioScrip, Inc. provides home infusion and other home healthcare services. The Company�s services are designed to improve clinical outcomes for patients with chronic and acute healthcare conditions while controlling overall healthcare costs. The Company�s platform provides nationwide service capabilities and the ability to deliver clinical management services that offer patients a high-touch, home-based and community-based care environment. Its core services are provided in coordination with, and under the direction of the patients' physicians. The Company�s multidisciplinary team of clinicians, including pharmacists, nurses, dietitians, respiratory therapists and physical therapists, work with the physician to develop a plan of care suited to its patients� specific needs. In February 2013, the Company acquired 100% of the ownership interest in HomeChoice Partners, Inc., a Delaware corporation (HomeChoice). HomeChoice is a provider of alternate-site infusion pharmacy services.

Officers and directors

Myron Z. Holubiak Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Richard M. Smith President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Thomas F. Pettit Chief Operating Officer, Senior Vice President
Age: 46
Bio & Compensation  - Reuters
Vito Ponzio Jr. Senior Vice President, Chief Administrative Officer
Age: 60
Bio & Compensation  - Reuters
Brian Stiver Senior Vice President of Sales and Marketing
Age: 52
Bio & Compensation  - Reuters
Donna Trujillo Senior Vice President of Human Resources
Age: 52
Bio & Compensation  - Reuters
Karen Cain Senior Vice President, Chief Strategy and Transformation Officer
Age: 60
Bio & Compensation  - Reuters
David Evans Senior Vice President- Strategic Operations And Reimbursement
Age: 51
Bio & Compensation  - Reuters
Barbara Cormier Chief Compliance Officer and Privacy Officer
Age: 72
Bio & Compensation  - Reuters
Patricia Bogusz Vice President - Finance, Principal Accounting Officer
Age: 55
Bio & Compensation  - Reuters